Ranok Therapeutics Secures $40 Million Series B Financing To Advance Its Innovative Targeted Protein Degradation Pipeline
Amount Raised
$40 Million
Round Type
Series B
BostonCommerce And ShoppingHealth CareDescription
Ranok Therapeutics (Hangzhou) Co. Ltd., an emerging biopharmaceutical company focused on developing breakthrough therapies for cancer and other serious diseases, today announced it had secured a $40 million Series B funding round denominated in both U.S. dollars and Chinese yuan. The financing was led by Lapam Capital and Shanghai Healthcare Capital, with additional participation from Wu Capital, Zhongguancun Kaiyuan Capital and existing investors, and representatives of the new investors will join Ranok’s expanded board of directors
Quick answer
Ranok Therapeutics raised $40 Million in a Series B round, dated August 18, 2021. Ranok Therapeutics is based in Boston, Massachusetts, United States.
- How much did Ranok Therapeutics raise?
- Ranok Therapeutics raised $40 Million in a Series B round on August 18, 2021.
- What does Ranok Therapeutics do?
- Ranok is a privately held, emerging biopharmaceutical company that is pioneering its proprietary CHAMP platform technology, an innovative approach to targeted protein degradation (TPD) for the discovery and development..
- Where is Ranok Therapeutics based and how big is it?
- Ranok Therapeutics is based in Boston, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Commerce And Shopping and Health Care around the same time
Companies in the same sectors as Ranok Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- ReadiVet raised an undisclosed amount (Funding Round) on August 4, 2021.
- Mixlab raised $20M (Funding Round) on August 2, 2021.
- Fresenius Medical Care raised $2.7M on October 1, 2021.
- Fresenius Medical Care raised $3.8M on October 1, 2021.
- Virtual Incision raised $4M on October 1, 2021.
- Ilumivu, Inc. raised an undisclosed amount on October 1, 2021.
Who to call at Ranok Therapeutics, and when
A new round usually means Ranok Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ranok Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ranok Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ranok Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ranok Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansRanok Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.